CNE100004BM0
CNE100004BM0
CANSINO BIOLOGICS INC
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.059.393.000 | 824.884.000 | 28.4% |
| Cost of Revenue | 260.131.000 | 244.432.000 | 6.4% |
| Gross Profit | 799.262.000 | 580.452.000 | 37.7% |
| 784.566.000 | 937.220.000 | 16.3% | |
| Operating Income | 14.696.000 | -356.768.000 | 104.1% |
| Pretax Income | 21.738.000 | -381.204.000 | 105.7% |
| Net Income Common Stockholders | 27.873.000 | -378.884.000 | 107.4% |
| -- | -- | -- | |
| -- | -- | -- |